Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia

Bruce D. Cheson, John C. Byrd, Kanti R. Rai, Neil Elliot Kay, Susan M. O'Brien, Ian W. Flinn, Adrian Wiestner, Thomas J. Kipps

Research output: Contribution to journalArticle

136 Scopus citations
Original languageEnglish (US)
Pages (from-to)2820-2822
Number of pages3
JournalJournal of Clinical Oncology
Volume30
Issue number23
DOIs
StatePublished - 2012

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cheson, B. D., Byrd, J. C., Rai, K. R., Kay, N. E., O'Brien, S. M., Flinn, I. W., Wiestner, A., & Kipps, T. J. (2012). Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia. Journal of Clinical Oncology, 30(23), 2820-2822. https://doi.org/10.1200/JCO.2012.43.3748